A Bcr-Abl tyrosine kinase inhibitor, Dasatinib is an anti cancer drug. It is administered orally and used for the treatment of prostrate cancer and many other cancers. It is a Src family tyrosine kinase inhibitor used for treating leukemia.. Reference standards of Dasatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => N-(2-Chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)(nitroso)amino)thiazole-5-carboxamide [catalogue_number] => PA 04 0071022 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 517.01 [form] => C22H25ClN8O3S [cas] => NA [pslug] => n-2-chloro-6-methylphenyl-2-6-4-2-hydroxyethyl-piperazin-1-yl-2-methylpyrimidin-4-yl-nitroso-amino-thiazole-5-carboxamide-pa040071022 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 0071022
CAS :
Molecular Formula : C22H25ClN8O3S
Molecular Weight : 517.01
stdClass Object ( [pname] => N-(2-Chloro-6-methylphenyl)-2-((2-methyl-6-(4-nitrosopiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide [catalogue_number] => PA 04 0071040 [category_ids] => ,78,70,82,162, [chemical_name] => [weight] => 472.95 [form] => C20H21ClN8O2S [cas] => 2135905-86-9 [pslug] => 2135905-86-9-n-2-chloro-6-methylphenyl-2-2-methyl-6-4-nitrosopiperazin-1-yl-pyrimidin-4-yl-amino-thiazole-5-carboxamide-pa040071040 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 0071040
Molecular Formula : C20H21ClN8O2S
Molecular Weight : 472.95
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
